TotalMarketCap

Propanc Biopharma

PPCBNasdaq AustraliaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.724 M

$1.67 -6.80%

Close of 6 Nov 2026

As of 6 Nov 2026, Propanc Biopharma (PPCB) has a market capitalization of $1.72M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$58.9M

Loss-making

Shares outstanding

6,331,116

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #484GeoVax LabsGOVX$1.95M
  2. #485EnlivexENLV$1.95M
  3. #486Propanc BiopharmaPPCB$1.72M
  4. #487GenprexGNPX$1.70M
  5. #488XORTX TherapeuticsXRTX$1.65M

What if Propanc Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$27,331,857

Per share 16,383,059× higher

Bitcoin $1.53T

$1,478,879

Per share 886,459× higher

Apple $5.02T

$4,855,022

Per share 2,910,161× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Propanc Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.